These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Persistent chemosensitivity to platinum and/or paclitaxel in metastatic endometrial cancer.
    Author: Markman M, Kennedy A, Webster K, Kulp B, Peterson G, Belinson J.
    Journal: Gynecol Oncol; 1999 Jun; 73(3):422-3. PubMed ID: 10366471.
    Abstract:
    It has long been recognized that individuals with ovarian cancer who initially respond to a platinum-containing chemotherapeutic regimen may exhibt a second response to platinum (cisplatin or carboplatin) at the time of recurrence. In this report, we describe three individuals with metastatic endometrial cancer who demonstrated secondary responses to platinum/paclitaxel-based regimens. Endometrial cancer should be added to the list of malignancies for which platinum and/or paclitaxel are considered as second-line treatment options in patients previously responding to the agents.
    [Abstract] [Full Text] [Related] [New Search]